MedPath
NMPA Approval

Ligustrazine Hydrochloride Injection

国药准字H20055479

September 5, 2019

Drug Information

盐酸川芎嗪注射液

注射剂

2ml:40mg

化学药品

September 5, 2019

Company Information

Applicant Company

新郑市人民东路北侧

Manufacturing Company

新郑市人民路北侧

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸川芎嗪注射液 - NMPA 批准文号 | MedPath